These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21103828)

  • 1. Prospective quality of life impact of actinic keratoses: observations from the veterans affairs topical tretinoin chemoprevention trial.
    Lee K; Weinstock M
    Acta Derm Venereol; 2011 Jan; 91(1):101-2. PubMed ID: 21103828
    [No Abstract]   [Full Text] [Related]  

  • 2. Reliability of counting actinic keratoses before and after brief consensus discussion: the VA topical tretinoin chemoprevention (VATTC) trial.
    Weinstock MA; Bingham SF; Cole GW; Eilers D; Naylor MF; Kalivas J; Taylor JR; Gladstone HB; Piacquadio DJ; DiGiovanna JJ
    Arch Dermatol; 2001 Aug; 137(8):1055-8. PubMed ID: 11493098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial.
    Weinstock MA; Lee KC; Chren MM; Marcolivio K;
    J Am Acad Dermatol; 2009 Aug; 61(2):207-15. PubMed ID: 19398145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective quality of life impact of keratinocyte carcinomas: observations from the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
    Lee KC; Weinstock MA;
    J Am Acad Dermatol; 2010 Dec; 63(6):1107-9. PubMed ID: 21093671
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical treatment of actinic keratoses with piroxicam 1% gel: a preliminary open-label study utilizing a new clinical score.
    Campione E; Diluvio L; Paternò EJ; Chimenti S
    Am J Clin Dermatol; 2010; 11(1):45-50. PubMed ID: 20000874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial.
    Weinstock MA; Bingham SF; Digiovanna JJ; Rizzo AE; Marcolivio K; Hall R; Eilers D; Naylor M; Kirsner R; Kalivas J; Cole G; Vertrees JE;
    J Invest Dermatol; 2012 Jun; 132(6):1583-90. PubMed ID: 22318383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of increased actinic keratosis count on skin-related quality of life: results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial.
    Beatson M; Siegel JA; Chren MM; Weinstock MA
    Eur J Dermatol; 2019 Oct; 29(5):507-510. PubMed ID: 31647464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
    Criscione VD; Weinstock MA; Naylor MF; Luque C; Eide MJ; Bingham SF;
    Cancer; 2009 Jun; 115(11):2523-30. PubMed ID: 19382202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial.
    Dyer RK; Weinstock MA; Cohen TS; Rizzo AE; Bingham SF;
    J Invest Dermatol; 2012 Nov; 132(11):2544-51. PubMed ID: 22810303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current issues in the management of actinic keratosis.
    Ceilley RI; Jorizzo JL
    J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S28-38. PubMed ID: 23228304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical tretinoin therapy and all-cause mortality.
    Weinstock MA; Bingham SF; Lew RA; Hall R; Eilers D; Kirsner R; Naylor M; Kalivas J; Cole G; Marcolivio K; Collins J; Digiovanna JJ; Vertrees JE;
    Arch Dermatol; 2009 Jan; 145(1):18-24. PubMed ID: 19153339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between non-steroidal anti-inflammatory drugs and keratinocyte carcinomas of the skin among participants in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
    Nunes AP; Lapane KL; Weinstock MA;
    Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):922-9. PubMed ID: 21688346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging drugs for actinic keratosis.
    Ulrich M; Drecoll U; Stockfleth E
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):545-55. PubMed ID: 20670178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Another approach to actinic keratosis management using nonablative fractional laser.
    Pearce DJ; Williford PM
    J Dermatolog Treat; 2014 Aug; 25(4):298. PubMed ID: 23331072
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-ablative fractional resurfacing in combination with topical tretinoin cream as a field treatment modality for multiple actinic keratosis: a pilot study and a review of other field treatment modalities.
    Prens SP; de Vries K; Neumann HA; Prens EP
    J Dermatolog Treat; 2013 Jun; 24(3):227-31. PubMed ID: 22515664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of photodamaged skin with trichloroacetic acid and topical tretinoin.
    Humphreys TR; Werth V; Dzubow L; Kligman A
    J Am Acad Dermatol; 1996 Apr; 34(4):638-44. PubMed ID: 8601654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical tretinoin in actinic keratosis and basal cell carcinoma.
    Peck GL
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):829-35. PubMed ID: 3534022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actinic keratosis: facts and controversies.
    Ko CJ
    Clin Dermatol; 2010; 28(3):249-53. PubMed ID: 20541675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eruptive milia and rapid response to topical tretinoin.
    Connelly T
    Arch Dermatol; 2008 Jun; 144(6):816-7. PubMed ID: 18559787
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses.
    Dirschka T; Bierhoff E; Pflugfelder A; Garbe C
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):258-63. PubMed ID: 19709346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.